Влияние периферического введения лоперамида на центральные механизмы пищевого поведения крыс
Диссертация
Нынешняя эпидемия ожирения частично обусловлена чрезмерным потреблением вкусной пищи и как следствие, формированием патологического подкрепления к ней (Blundell J.E., Gillett А., 2001; Bray G.A. et al., 1992; Hill J.O., Peters J.C., 1998; Ludwig D.S. et al., 2001). Переедание является важной проблемой общественного здравоохранения в силу своей сильной ассоциации с другими медицинскими… Читать ещё >
Список литературы
- Анохин П. К. Философские аспекты теории функциональной системы: Избранные труды. М.: Наука, 1978. — 400 с.
- Анохин П.К. Биология и нейрофизиология условного рефлекса.- М.: Медицина, 1968.- 640 с.
- Анохина И.П. Основные биологические механизмы алкогольной и наркотической зависимости // Вопросы наркологии. 2002.Т.1.- С. 33.
- Ашмарин И.П. Регуляторные пептиды, происхождение и иерархия // Журнал эволюционной биохимии и физиологии. 1982. — Т. 18 — № 1. -С. 3−10.
- Булаев В. М. Рецепторы опиатов и их лиганды // Итоги науки и техники: Сер. фармакология. Химиотерапевт, средства. М.: ВИНИТИ, 1982.-№ 13.-С. 101−184.
- Вальдман A.B., Бабаян Э. А., Звартау Э. Э. Психофармакологические и медико-правовые аспекты токсикоманий. Москва. Изд-во Медицина. 1988. СС. 27,211,288.
- Варфоломеев С.Д., Зайцев C.B., Mebx А.Т. Физико-химические исследования молекулярных механизмов действия физиологически активных соединений. Рецепция // Итоги науки и техники. Сер. Биоорг. Хим. -М., 1985.-Т. 3.
- Дубынин В.А., Асмакова Л. С., Соханенкова Н. Ю. и др. Сравнительный анализ нейротропной активности экзорфинов производных пищевых белков // Бюлл. эксперим. Биол. и медицины. — 1998. — Т. 125 — № 2. — С. 153−157.
- Зайцев C.B., Курочкин И. П., Породенко Н. В. Физико-химические подходы к анализу взаимодействия пептидов с гетерогенной популяцией рецепторов // Олигопептиды как регуляторы функций организма / Под ред. В. Н. Ярыгина, Е. И. Гусева. М., 1987. С. 5−16.
- Зайцев C.B., Сергеева М. Г., Варфоломеев С. Д. Радиорецепторный анализ: теоретические основы метода // Биоорган. Хим. 1985. Т. 11. -№ 3. — С. 370−379.
- Звартау Э. Э., Кузьмин А. В. Новые аспекты изучения аддиктив-ных эффектов наркотических анальгетиков. //Анест. и реаниматол. 1996. -№ 4. — С. 13−16.
- Звартау Э.Э. // Методология изучения наркотоксикоманий. Итоги науки и техн. ВИНИТИ. Сер. Наркология. М., 1988. Т. 1. — С. 168.
- Золоев Т.К., И.В. Боброва, Н.И. Хабарова, H.A. Абиссова Некоторые механизмы участия опиоидных пептидов в регуляции углеводного обмена // Бюл. эксперим. биологии и медицины. 1992. — Т. 113. — № 3. — С. 257−259.
- Кендыш И. Н. Регуляция углеводного обмена М. «Медицина», 1985. -272 с.
- Машковский М.Д. Лекарственные средства: Пособие для врачей., 14-е изд., М.: Новая Волна, 2002.
- Метелица В.И. Справочник по клинической фармакологии сердечнососудистых лекарственных средств. М.: Медпрактика, 1996. — С. 784.
- Рудин И.В., Медведев М. А. Опиоидные пептиды модулируют секрецию основных детерминант желчетока // Бюл. эксперим. биологии и медицины. 1997. — Т. 123. — № 5. — С. 498−500.
- Сиволап Ю.П., Савченков В. А. Злоупотребление опиоидами и опиоидная зависимость. М.- «Медицина», 2005. 15−79 с.
- Судаков К.В. Мотивация и подкрепление в системных механизмах поведения: динамические энграммы подкрепления // Журнал высш. нервн. деят. им. И. П. Павлова. 1995. Т. 45. — №. 4. — С. 627−637.
- Судаков К.В. Физиология. Основы и функциональные системы: курс лекций / Под редакцией К. В. Судакова. М.: Медицина, 2000. С. 448 463.
- Судаков С.К. Индивидуальная предрасположенность к опийной наркомании. Экспериментальные исследования. М.: Издательский дом «Нарконет», 2002. — С. 27.
- Судаков С.К., Альтшуллер В. Б. Апротинин как средство для купирования опийной абстиненции //Вестн. нов. мед. технол. 1998. -Т. 5. — № 1. — С. 72−75.
- Судаков С.К., Русакова И. В. Влияние иммунизации крыс антиморфиновыми антителами на чувствительность к морфину и предрасположенность к формированию зависимости // Бюл. экспер. биол. 2005. — Т. 140. — № 11. — С. 535−538.
- Судаков С.К., Русакова И. В., Тригуб М. М., Помыткин И. А. Метилналоксон подавляет синдром отмены у морфинзависимых крыс // Бюл. экспер. биол. 2007. — Т. 143. — № 5. — С. 545−547.
- Судаков С.К., Судаков К. В. Церебральные механизмы опиатной зависимости // Наркология. 2003. — № 1. — С. 38.
- Судаков С.К., Теребилина H.H., Медведева О. Ф. и др // Нейрохимия. -2000. Т. 17. — № 3. — С. 207−210.
- Судаков С.К., Тригуб М. М. Гипотеза реципрокного взаимодействия центрального и периферического звена эндогенной опиоидной системы // Бюл. экспер. биол. 2008. — Т. 146. — № 12. — С. 604−607.
- Судаков С.К., Чумакова Ю. А., Башкатова В. Г. Участие эндогенной опиоидной системы в механизмах сенсорного насыщения // Экспериментальная и прикладная физиология. «Системная саморегуляция функций организма». 2011. — Т. 16. — С. 39−47.
- Тимофеев И.С. Тканевой микродиализ: принципы и клиническое применение метода в интенсивной терапии // Интенсивная терапия. -2007.-№ 1.-С.45.
- Ткаченко Н.М. В сб. «Материалы VI Всес. конф. по электрофизиологии центральной нервной системы» JL «Наука» 1971. С. 46−47.
- Харкевич Д. А. Фармакология: Учебник., 7-е изд., М.: ГЭОТАР Медицина. 2002.
- Шабанов П.Д., Штакельберг О. Ю. Наркомания: патопсихология, клиника, реабилитация / Под. ред. А. Я. Гриненко. Серия «Мир медицины» СПб.: Издательство «Лань», 2000. 29 с.
- Abbadie С., Pan Y.X., Pasternak G W. Immunohistochemical study of the expression of exonl 1-containing mu opioid receptor variants in mouse brain //Neuroscience. 2004. — Vol. 127. — P. 419−430.
- Abood L.G., Atkinson G.H., MacNeil M. Stereospecific opiate binding in human erythrocyte membranes and changes in heroin addicts // J. Neurosci. Res. 1976. — Vol. 2(2−5). — P. 427−431.
- Adam T.C., Epel E.S. Stress, eating and the reward system // Physiology and Behavior. 2007. — Vol. 91 — P. 449−458.
- Ahmed M.S., Horst M.A. Opioid receptors of human placental villi modulate acetylchline release // Life Sci. 1986. — Vol. 39. — № 6. — P. 535 540.
- Ahn S., Nelson C.D., Garrison T.R., Miller W.E., Lefkowitz R.J. Desensitization, internalization, and signaling functions of beta-arrestins demonstrated by RNA interference // Proc. Natl. Acad. Sci. USA. — 2003. Vol. 100. P. 1740−1744.
- Akil H., Young E., Watson S.J., Coy D.H. Opiate binding properties of naturally occurring N- and C-terminus modified beta-endorphins // Peptides. 1981.-Vol. 2.-P. 282−289.
- Allan E.H., Green I.C., Titheradge M.A. The stimulation of glycogenolysis and gluconeogenesis in isolated hepatocytes by opioid peptides // Biochem J. 1983. — Vol. 216. — N 2. — P. 507−510.
- Angulo J.A., McEwen B.S. Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens // Brain Res Rev. 1994.-Vol. 19.-P. 1−28.
- Appleyard S.M., Hayward M., Young J.I., Butler A.A., Cone R.D., Rubinstein M., Low M.J. A role for the endogenous opioid beta-endorphin in energy homeostasis // Endocrinology. 2003. — Vol. 144. — N 5. — P. 17 531 760.
- Arttamangkul S., Torrecilla M., Kobayashi K., Okano H., Williams J.T. Separation of mu-opioid receptor desensitization and internalization: endogenous receptors in primary neuronal cultures // J Neurosci. 2006. -Vol. 26. -P. 4118−4125.
- Atkinson R.L. Opioid regulation of food intake and body weight in humans //Fed Proc. 1987.-Vol. 46.-N1.-P. 178−182.
- Attali B., Gonarderes C., Mazarguil H. et al. Differential interaction of opiates to multiple «kappa» binding sites in the guinea-pig lumbosacrol spinal cord//Life Sci. 1982. — Vol. 31. -N 12−13. — P. 1371−1375.
- Atweh S.F., Kuhar M.J. Autoradiographic localization of opiate receptors in rat brain -1. Spinal cord and lower medulla // Brain Res. 1977. — Vol. 124. -N l.P. 53−67.
- Auernhammer C.J., Stalla G.K., Lange M., Pfeiffer A., Muller O.A. Effects of loperamide on the human hypothalamo-pituitary-adrenal axis in vivo and in vitro // J Clin Endocrinol Metab. 1992. — Vol. 75. — P. 552−557.
- Avena N.M. Examining the addictive-like properties of binge eating using an animal model of sugar dependence // Experimental and Clinical Psychopharmacology. 2007. — Vol. 15. — P. 481−491.
- Avena N.M., Long K.A., Hoebel B.G. Sugar-dependent rats show enhanced responding for sugar after abstinence: evidence of a sugar deprivation effect. // Physiol Behav. 2005. — Vol. 84. — P. 359−362.
- Avena N.M., Rada P., Hoebel B.G. Evidence for sugar addiction: behavioral and neurochemical effects of intermittent, excessive sugar intake. // Neuroscience and Biobehavioral Reviews. 2008. — Vol. 32. — P. 20−39.
- Balleine B.W. Neural bases of food seeking: Affect, arousal and reward in corticostriatolimbic circuits // Physiol Behav. 2005. — Vol. 86. — P. 717 730.
- Barbano M.F., Cador M. Opioids for hedonic experience and dopamine to get ready for it // Psychopharmacology. 2007. — Vol. 191.- N 3. — P. 497 506.
- Barbel O., Riepl R.L., Carsten O., et al. ji-Opiate receptor agonists a new pharmacological approach to prevent motion sickness? // Br J Clin Pharmacol. — 2006. — Vol. 61. — N 1. — P. 27−30.
- Beverly C.L., Higgins P.J., Borenfreund E. The effect of methadone and naloxone on cultured rat liver cells // Exp. Cell Biol. 1984. — Vol. 52. — N 1. -P. 12−17.
- Bianchi G., Ferretti P., Recchia M. et al. Morphine tissue levels and reduction of gatroitestinal transit in rats // Gastroenterology. 1983. — Vol. 85.-N2.-P. 852−858.
- Binder H.I., Laurenson J.P., Dobbins J.W. Role of opiate receptors in regulation of enkephalin stimulation of active sodium and chloride adsorption // Am. J. Physiol. 1984. — Vol. 247. — N 4. — P. 432−436.
- Bitar K.N., Makhlouf G.M. Selective presence of opiate receptors on intestinal cicular muscle cells // Life Sci. — 1985. — Vol. 37. — N 16. — P. 15 451 550.
- Blundell J.E., Gillett A. Control of food intake in the obese // Obes Res. -2001.-Vol. 9.-P. 263−270.
- Borlongan C.V., Wang Y., Su T.P. Delta opioid peptide (D-Ala 2, DLeu 5) enkephalin: linking hibernation and neuroprotection // Front. Biosci. 2004.- N 9. P. 3392−3398.
- Bozarth M.A. The mesolimbic dopamine system as a model brain reward system., In P. Willner and J. Scheel-Kriiger (eds.), The mesolimbic dopamine system: From motivation to action. London: John Wiley & Sons.- 1991.-P. 301−330.
- Bozarth M.A., The mesolimbic dopamine system as a model brain reward system., In P. Willner and J. Scheel-Kriiger (eds.), The mesolimbic dopamine system: From motivation to action. London: John Wiley & Sons. 1991. P. 301−330.
- Bray G. A. Obesity: a time bomb to be defused Lancet. 1998. — Vol. 352. -N. 18. — P. 160−161.
- Bray G.A., York B., DeLany J. A survey of the opinions of obesity experts on the causes and treatment of obesity // Am J Clin Nutr. 1992. — Vol. 55. -P. 151−154.
- Bridges R.J., Rack M., Rummel W. et al. Mucosal plexus and electrolyte transport across the rat colonic mucosa // J. Physiol. 1986. — Vol. 376. -P. 531−542.
- Broccardo M., Improta G., Tabacco A. Central effect of SNC 80, a selective and systemically active 5-opioid receptor agonist, on gastrointestinal propulsion in the mouse // Eur J Pharmacol. 1998. — Vol. 342. — P. 247 251.
- Brust J.C.M. Neurological aspects of substance abuse. -2nd ed. -Philadephia: Elsevier Inc. 2004. — P. 477.
- Burattini C., Burbassi S., Aicardi G., Cervo L. Effects of naltrexone on cocaine- and sucrose-seeking behaviour in response to associated stimuli in rats // Int J Neuropsychopharmacol. 2008. — Vol. 11. — P. 103−109.
- Cabanac M. Pleasure: The common currency // J Theor Biol. 1992. — Vol. 155.-N2.-P. 173−200.
- Cacicedo L., Franco F.S. Direct action of opioid peptides and naloxone on gonadotropin secretion by cultured rat-anterior pituitary cells // Life Sci. -1986. Vol. 38. — N 7. — P. 617−625.
- Capasso A., Sorrentino L., Di Giannuario A. et al. Effect of des-tyrosine-y-endorphin on neocortical spike-and-wave spindling in DBA/2J mice // Eur. J. Pharmacol. 1994. — Vol. 261. — N 1−2. — P. 209−212.
- Carmichael A. R. Treatment for morbid obesity. Postgrad Med J. 1999. Vol. 75.-N879. P. 7−12.
- Carr K.D. Feeding, drug abuse, and the sensitization of reward by metabolic need//Neurochem Res. 1996. — Vol. 21. — P. 1455−1467.
- Carr K.D., Simon E.J. The role of opioids in feeding and reward elicited by lateral hypothalamic electrical stimulation // Life Sci. 1983. — N 1. — P. 563 566.
- Chang K.J., Cuatrecasas P. Multiple opiate receptors // J. Biol. Chem. -1979. Vol. 254. — N 8. — P. 2610−2618.
- Chao C.C., Moss G.E., Maloen P.V. Direct opioid regulation of pituitary release of bovine luteinizing hormone // Life Sci. 1986. — Vol. 39. — N 6. -P. 527−534.
- Chaturvedi K. Opioid peptides, opioid receptors and mechanism of down regulation / K. Chaturvedi // Indian. J. Exp. Biol. 2003. — Vol. 41. — N 1. -P. 5−13.
- Chavkin C., Golstein A. Demonstration of a specific dynorphin receptor in guinea-pig ileum myenteric plexus // Nature. 1981. — Vol. 291. — N 5816. -P. 591−593.
- Chavkin C., James Z.F., Golstein A. Dynorphin is a specific endogenous ligand of the kappa opioid receptor // Science. -1982. -Vol. 215. -N 4531. -P. 413−415.
- Chen R.Z., Huang R.R., Shen C.P. et al. Chronic administration of nalmefene leads to increased food intake and body weight gain in mice // Eur J Pharmacol. 2004. — Vol. 495. — N 1. — P.63−66.
- Choi H.S., Kim C.S., Hwang C.K., et al. The opioid ligand binding of human mu-opioid receptor is modulated by novel splice variants of the receptor // Biochem Biophys Res Commun. 2006. — Vol. 343. — P. 1132— 1140.
- Chretien B., Benjannet S., Dragon N., Seidah N.G., Lis M. Biochem. Biophys. Res. Commun. 1976. — Vol. 72. — P. 472−478.
- Clapham D.E., Neer E.J. G protein beta gamma subunits // Annu Rev Pharmacol Toxicol. 1997. — Vol. 37. — P. 167−203.
- Colantuoni C., Rada P., McCarthy J., Patten C., Avena N.M., Chadeayne A., et al. Evidence that intermittent, excessive sugar intake causes endogenous opioid dependence // Obesity Research. 2002. — Vol. 10. — P. 47888.
- Colantuoni C., Schwenker J., McCarthy J., Rada P., Ladenheim B., Cadet J.L., et al. Excessive sugar intake alters binding to dopamine and mu-opioid receptors in the brain // NeuroReport. 2001. — Vol. 12. — P. 3549−3552.
- Cole J.L., Leventhal L., Pasternak G.W., Bowen W.D., Bodnar R.J. Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in rats // Brain Res. -1995. Vol. 678. — N 1−2. — P. 168−176.
- Comb J., Seeburg P.H., Adelman J., Eiden L., Herbert E. Primary Structure of the Human Met- and Leu-enkephalin Precursor and its mRNA // Nature. -1982.-Vol. 295.-P. 663−667.
- Connor M., Christie M.D. Opioid receptor signalling mechanisms // J. Clin Exp Pharmacol Physiol. 1999. — Vol. 26. — P. 493−499.control in obese female subjects. Int. J. Obes. 1994. — Vol. 18. — P. 838.
- Cosman K.M., Boyle L.L., and Porsteinsson A. P. Memantine in the treatment of mild-to-moderate Alzheimer’s disease // Expert. Opin. Pharmacother. 2007. — Vol. 8. — N 2. — P. 203−214.
- Creese I., Snyder S.H. Receptor binding and pharmacological activity of opiates in the guinea pig intestine // J. Pharmacol. Exp. Ther. 1975. — Vol. 194.-Nl.-P. 205−219.
- Crowther J.H., Sanftner J., Bonifazi D.Z., Shepherd K.L. The role of daily hassles in binge eating // International Journal of Eating Disorders. 2001. -Vol. 29. — P. 449−454.
- Damasio A.R. The somatic marker hypothesis and the possible functions of the prefrontal cortex // Philos Trans R Soc Lond B Biol Sci. 1996. — Vol. 351. -N 1346. — P. 1413−1420.
- Dashwood M.R., Debnam E.S., Burks T.R. et al. Autoradiographic localization of opiate receptors in rat small intestine // Europ. J. Pharmacol. -1985. Vol. 162. — N 1. — P. 267−269.
- Dave J.R., Rubinstein N., Eskay R.L. Evidence that beta-endorphin binds to specific receptors in rat peripheral tissues and stimulates the adenylate cyclase-adenosine 3', 5'-monophosphate system // Endocrinolody. 1985. -Vol. 117.-N4.-P. 1389−1396.
- Davison J.S., Clarke G.D. Mechanical properties and sensitivity to CCK of vagal gastric slowly adapting mechanoreceptors // Am J Physiol. 1988. -Vol. 255.-N1.-P. 55−61.
- DeHaven-Hudkins D.L., Burgos L.C., Cassel J.A., et al.: Loperamide (ADL 2−1294), an opioid antihyperalgesic agent with peripheral selectivity. J. Pharmacol. Exp. Ther. 1999. — Vol. 289. — N 1. — P. 494−502.
- Deneau G., Yanagita T., Seevers M.H. Self-administration of psychoactive substances by the monkey: a measure of psychological dependence. Psychopharmacologia. 1969. Vol. 16. P. 30−48.
- Devi L.A. Heterodimerization of G protein-coupled receptors: pharmacology, signaling and trafficking // Trends Pharmacol Sci. 2001. -Vol. 22. — P. 532−537.
- DiChiara C., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolibic system of freely moving rats // Proc. Natl. Acad. Sci. USA. 1988. — Vol. 85. — P. 5274−5278.
- Dickinson A., Balleine B.W. Motivational control of goal-directed action // Anim Learn Behav. 1994. — Vol. 22. — P. 1−18.
- Donnerer J., Cardinale G., Coffey J. et al. Chemical characterization and regulation of endogenous morphine and codeine in the rat // J. Pharmacol. Exp. Ther. 1987. — Vol. 242. — N 2. — P. 583−587.
- Drewnowski A., Krahn D. D., Demitrack M. A. et al., Naloxone, an
- Dumitrascu D.L., Stanculete M., Mitrea I., Dumitrascu D.M., Farcas A. The effect of two antidiarrhoeal drugs on the psychosocial adjustment to illness in chronic functional diarrhea // Rom J Intern Med. 2004. — Vol. 42. — P. 191−197.
- Duvauchelle C.L., Fleming S.M., Kornetsky C. Involvement of delta- and mu-opioid receptors in the potentiation of brain-stimulation reward // Eur J. Pharmacol. 1996. — Vol. 316. — N 2−3. P. 137−143.
- Egleton R.D., Abbruscato T.J., Thomas S.A., Davis T.P. Transport of opioid peptides into the central nervous system // J. Pharm Sci. 1998. — Vol. 87. -N11.-P. 1433−1439.
- Endres-Becker J., Heppenstall P.A., Mousa S. et al.-receptor activation modulates TRPV1 currents in sensory neurons in a model of inflammatory pain. Mol Pharmacol- 2006. doi.TO.l 124/mol. 106.26 740
- Erickson C.K. Review of neurotransmitters and their role in alcoholism treatment // Alcohol and Alcoholism. 1996. — Vol. 31. — P. 5.
- Evans K.R., Vaccarino F.J. Amphetamine- and morphine-induced feeding: evidence for involvement of reward mechanisms // Neurosci Biobehav Rev. 1990.-Vol. 14.-P. 9−22.expression and endogenous leptin concentrations in a dietary model of
- Feldberg W., Cupta K.P. Morphine hyperglycaemia // J. Physiol. 1974. -Vol. 238.-N3.-P. 487−502.
- Ferrara P., Li C.H. (3-Endorphin: radioreceptor binding assay // Int. J. Peptide Protein Res. 1980. — Vol. 16. — N 1. — P. 66−69.
- Fichna J., Janecka A., Costentin J., Do Rego J.C. The endomorphin system and its evolving neurophysiological role // Pharmacol Rev. 2007. — Vol. 59. -P. 88−123.
- Finlayson G., King N., Blundell J. The role of implicit wanting in relation to explicit liking and wanting for food: Implications for appetite control // Appetite. 2008. — Vol. 50. — N 1. — P. 120−127.
- Finlayson G., King N., Blundell J.E. Is it possible to dissociate 'liking' and 'wanting' for foods in humans? A novel experimental procedure // Physiol Behav. 2007. — Vol. 90. — N. 1. — P. 36−42.
- Foote R.W. Fiber tracts that contain more opioid binding sites than gray matter does- a quantative autoradiographic study in the guinea-pig // Nueroscience. 1987. — Vol. 20.
- Freye E. Opioid agonists, antagonists and mixed narcotic analgesics. Springer-Verlag, 1987.
- Gadd C.A., Murtra P., De Felipe C., Hunt S.P. Neurokinin-1 receptor-expressing neurons in the amygdala modulate morphine reward and anxiety behaviors in the mouse // J Neurosci. 2003. — Vol. 23. — P. 8271−8280.
- Gainetdinov R.R., Premont R.T., Bohn L.M., Lefkowitz R.J., Caron M.G. Desensitization of G protein-coupled receptors and neuronal functions // Annu Rev Neurosci. 2004. — Vol. 27. — P. 107−144.
- Giagnoni G., Casiraghi L., Senini R., Revel L., Parolaro D., Sala M., Gori E. Loperamide: evidence of interaction with ji and opiod receptors // Life Sci. -1993.-Vol. 33.-P. 315−318.
- Gianoulakis C. Endogenous Opioids and Addiction to Alcohol and Other Drugs of Abuse. Curr Top Med Chem. 2009.
- Gianoulakis C., Gupta A. Inbred strains of mice with variable sensitivity to ethanol exhibit differences in the content and processing of fl-endorphin // Life Sci. 1986. — Vol. 39. — N 24. — P. 2315−2325.
- Gilbert P.E., Martin W.R. The effects of morphine- and nalorphine-like drugs in the nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog // J.Pharmacol. Exp. Ther. 1976. — Vol. 198. — P. 66−82.
- Gilmar S.C., Schwartz J.M., Milner R.J. et al. Beta-endorphin enhances lymphocyte proliferative responses // Proc. Natl. Acad. Sci. USA. 1982. -Vol.79. — N 13. — P. 4226−4230.
- Gintzler A.R., Chakrabarti S. Post-opioid receptor adaptations to chronic morphine- Altered functionality and associations of signaling molecules // Life Sci. 2006. — Vol. 79. — N 8. — P. 717−722.
- Glass M.J., Billington C.J., Levine A.S. Opioids and food intake: distributed functional neural pathways? // Neuropeptides. 1999. — Vol. 33. — P. 360 368.
- Goldfield G.S., Adamo K.B., Rutherford J., Legg C. Stress and the relative reinforcing value of food in female binge eaters // Physiology and Behavior. 2007. — Vol. 9. — P. 579−587.
- Goldstein A., Tachibana S., Lownwey L.I., Hunkapiller M., Hood L. Proc. Natl. Acad. Sci. USA. — 1979. — Vol. 76. — P. 6666−6670.
- Gosnell B.A., Levine A.S. Reward systems and food intake: role of opioids // Int J Obes (Lond). 2009. — Vol.33. — N 2. — P. 54−58.
- Gramsch C., Hollt V., Pasi A. et al. Immunoreactive dynorphin in human brain and pituitary // Brain Res. 1982. — Vol. 223. — N 1. — P. 65−74.
- Greenwald M., Johanson C.E., Bueller J., Chang Y., Moody D.E., Kilbourn M., et al. Buprenorphine duration of action: mu-opioid receptor availability and pharmacokinetic and behavioral indices // Biol Psychiatry. 2007. — Vol. 61.-P. 101−110.
- Grilo C.M., Masheb R.M., Wilson G.T. Subtyping binge eating disorder // Journal of Consulting and Clinical Psychology. 2001. — Vol. 69. — P. 10 661 072.
- Guderman T., Kalkbrenner F., Schultz G. Diversity and selectivity of receptor-G protein interaction // Annu Rev Pharmacol Toxicol. 1996. -Vol. 36. — P. 429159.
- Hackler L., Zadina J.E., Ge L. J, Kastin A.J. Isolation of relatively large amounts of endomorphin-1 and endomorphin-2 from human brain cortex // Peptides. 1997. — Vol. 18. — P. 1635−1639.
- Haddox M.K., Russell D.H. Beta-endorphyn is a kidney trophic hormone // Life Sci. 1979. — Vol. 25. — N 7. — P. 615−620.
- Hagan M.M., Rushing P.A., Benoit S.C., et al. Opioid receptor involvement in the effect of AgRP- (83−132) on food intake and food selection // Am J Physiol Regul Integr Comp Physiol. 2001. — Vol. 280. — P. 814−821.
- Hammers A., Asselin M.C., Hinz R., Kitchen I., Brooks D.J., Duncan J.S., et al. Upregulation of opioid receptor binding following spontaneous epileptic seizures // Brain. 2007. — Vol. 30. — P. 1009−1016.
- Handa B.K., Lane A.C., Lord C.A.H. et al. Analogues of beta-LPH6i64 possessing selective agonist activity at mu-opiate receptors // Europ. J. Pharmacol. 1981. — Vol. 70. — N 4. — P. 531−540.
- Hassan A.H.S., Ableitner A., Stein C. et al. Inflammation of the Rat Paw Enhances Axonal Transport of Opioid Receptors in the Sciatic Nerve and Increases their Density in the Inflamed Tissue // Neuroscience. 1993. — Vol. 55.-P. 185−195.
- Hazum E., Chang K.J., Cuatrecasas P. Specific nonopiate receptors for beta-endorphin // Science. 1979. — Vol. 205. — N 4410. — P. 1033−1035.
- Heel R.C., Brogden R.N., Speight T.M., Avery G.S. Loperamide: a review of its pharmacological properties and therapeutic efficacy in diarrhea // Drugs. 1978. — Vol. 15. — P. 33−52.
- Herve C., Fellmann D. Changes in rat melanin-concentrating hormone and dynorphin messenger ribonucleic acids induced by food deprivation // Neuropeptides. 1997. — Vol. 31. — P. 237−242.
- Heykants J., Michiels M., Knaeps A., Brugmans j. Loperamide (R18553), a novel type of antidiarrheal agent. Part 5: The pharmacokinetics of loperamide in rats and man // Arzneimittelforschung. 1974. — Vol. 24. — P. 1649−1653.
- Hill J.O., Peters J.C. Environmental contributions to the obesity epidemic // Science. 1998. — Vol. 280. — P. 1371−1374.
- Holzer P. Opioid receptors in the gastrointestinal tract // Regulatory Peptides. 2009 — Vol. 155- № 1−3 — P. 11−17.
- Ikemoto S., Panksepp J. The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special interference to reward -seeking // Brain Res. Rev. 1999. — Vol. 31.-N1.-P. 6
- Jabourian M., Venance L., Bourgoin S., et al. Functional mu opioid receptors are expressed in cholinergic interneurons of the rat dorsal striatum: territorial specificity and diurnal variation // Eur J Neurosci. 2005. — Vol. 21.-P. 3301−3309.
- Jacobson A.E., Bajwa B.S., Streaty R.A. et al. Probes for narcotic receptor mediated phenomena. 5. Narcotic antagonist irreversible ligands based on endoethenotetrahydrooripavine // Life Sci. 1983. — Vol. 33. — N 1. — P. 159 162.
- Janecka A., Fichna J., Janecki T. Opioid receptors and their ligands / // Curr. Top. Med. Chem. 2004. — N 1. — P. 1−17.
- Jewett D.C., Cleary J., Levine A.S., Schaal D.W., Thompson T. Effects of neuropeptide Y, insulin, 2-deoxyglucose, and food deprivation on food-motivated behavior // Psychopharmacology. 1995. — Vol. 120. — P. 267 271.
- Johnson P.M., Kenny P.J. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats // Nature Neuroscience. -2010.-Vol. 13.-P. 635−641.
- Jordan B.A., Cvejic S., Devi L.A. Opioids and their complicated receptor complexes //Neuropsychopharmacology. 2000. — Vol. 23. — P. 5−18.
- Josef S.A., Micheal G.J. Efferent ACTH- IR opiocortin projections from nucleus tractus solitarius: a hypothalamic deafferentation study // Peptides. -1988.-Vol. 9.-N1.-P. 193−201.
- Judd A.M., Hedge G.A. The roles of the opioid peptides in controlling thyroid stimulating hormone release // Life Sci. 1982. — Vol. 31. — N 22. — P. 2520−2536.
- Kakidani H., Furutani Y., Takehashi H., Noda M., Morimoto Y., Hirone T., Asai M., Inayama S., Nakanishi S., Numa S. Cloning and secuence analisys of cDNA for porcine beta-neo-endorphin, dynorphin precursor // Nature. -1982. Vol. 298. — P. 245−249.
- Kalivas P.W., Volkow N.D. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry. 2005. — Vol. 162(8). — P. 14 031 413.
- Kastin A.J., Fasold M.B., Zadina J.E. Endomorphins, Met-enkephalin, Tyr-MIF-1, and the P-glycoprotein efflux system // Drug Metab Dispos. 2002. -Vol. 30. — N 3. — P. 231−234.
- Kelley A.E. Ventral striatal control of appetitive motivation: role in ingestive behavior and reward-related learning // Neurosci. Biobehav. Rev. 2004. -Vol. 27. — P. 765−776.
- Kelley A.E., Bakshi V.P., Haber S.N., Steininger T.L., Will M.J., Zhang M. Opioid modulation of taste hedonics within the ventral striatum // Physiology and Behavior. 2002. — Vol. 76. — P. 365−377.
- Kelley A.E., Baldo B.A., Pratt W.E., Will M.J. Corticostriatal-hypothalamic circuitry and food motivation: integration of energy, action and reward // Physiology and Behavior. 2005. — Vol. 86. — P. 773−795.
- Kelley A.E., Will M.J., Steininger T.L., Zhang M., Haber S.N. Restricted daily consumption of a highly palatable food (chocolate Ensure®) alters striatal enkephalin gene expression // European Journal of Neuroscience. -2003. Vol. 18. — P. 2592−2598.
- Knapp R.J., Malatynska E., Collins N., Fang L., Wang J.Y., Hruby V.J., et al. Molecular biology and pharmacology of cloned opioid receptors // FASEB J. 1995. — Vol. 9. — P. 516−525.
- Koob G.F. Drugs of abuse: anatomy, pharmacology and function of reward pathways // Trends Pharmacol Sci. 1992. — Vol. 13. — N 5. — P. 177−184.
- Koob G.F. The neurobiology of addiction: a neuroadaptational view relevant for diagnosis // Addiction. 2006. — Vol. 101. — N 1. — P. 23−30.
- Koob G.F., Weiss F. Neuropharmacology of cocaine and ethanol dependence // Recent Dev Alcohol. 1992. — Vol. 10. — P. 201−233.
- Kreeger D.T., Liotta A., Brownstein M.J. Presence of cortico- tropin in brain of normal and hypophysectomized rats // Proc.Natl.Acad.Sci. USA. -1977.-Vol. 74.-P. 648−652.
- Kromeyer-Hauschild K., Zellner K., Jaeger U., Hoyer H. Prevalence of overweight and obesity among school children in Jena // Int J. Obes. Relat. Metab. Disord. Germany. — 1999. — Vol. 23. — P. 1143- 1150.
- Kuhar M.J. The mismatch problem in receptor mapping studies // Trends Neurosci. 1985. — Vol. 8. — N 5. — P. 291.
- Kuhar M.J., Unnerstall J.R. Quantative receptor mapping by autoradiography- some current technical problems // Trends Neurosci. -1985.-Vol. 8.-N2.-P. 49−53.
- La Fleur. S.E., Vanderschuren L.J., Luijendijk M.C., et al. A reciprocal interaction between food-motivated behavior and diet-induced obesity // International Journal of Obesity. 2007. — Vol. 31. — P. 1286−1294.
- Lauterio TJ, Davies MJ, DeAngelo M, Peyser M, Lee J Neuropeptide Y
- Law P.Y., Wong Y.H., Loh H.H. Molecular mechanisms and regulation of opioid receptor signaling // Annu Rev Pharmacol Toxicol. 2000. — Vol. 40. — P. 389−430.
- Lawton C. L., Wales J. K., Blundell J. E. Dietary fat and appetite
- Leach P.P., Shears S.B., Kirk C.J. et al. Changes in free cytosolic calcium and accumulation of inositol phosphate in isolated hepatocytes by leu. enkephalin // Biochem. J. 1986.- Vol. 238. — N 2. — P. 537−542.
- Lee N.M., Smith A.P. A protein-lipid model of the opiate receptor // Life Sci. 1980. — Vol. 26. — N 18. — P. 1459−1464.len female binge eaters. Am. J. Clin. Nutr. 1995. — Vol. 61. — N. 6. — P. 1206−1212.
- Lenoir M., Serre F., Cantin L., Ahmed S.H. Intense sweetness surpasses cocaine reward // PLoS One. 2007. — Vol. 2. — P. 698.
- Levine A.S., Billington C.J. Opioids as agents of reward-related feeding: a consideration of the evidence // Physiol Behav. 2004. — Vol. 82. — P. 57−61.
- Levine A.S., Kotz C.M., Gosnell B.A. Sugars and fats: the neurobiology of preference // J. Nutr. 2003. — Vol. 133. — P. 831−834.
- Levine A.S., Morley J.E., Gosnell B.A., Billington C.J., Bartness T.J. Opioids and consummatory behavior // Brain Res Bull. 1985. — Vol. 14. -P. 663−672.
- Li J.P., Lee K.Y., Chang T.M., et al. Chey /MEK inhibits secretin release and pancreatic secretion: roles of secretin-releasing peptide and somatostatin. Am. J. Physiol. Gastrointest // Liver Physiol. 2001. — Vol. 280. — N 5. — P. 890−896.
- Lowy M.T., Yim G.K. Stimulation of food intake following opiate agonists in rats but not hamsters // Psychopharmacology (Berl). 1983. — Vol. 81. — N l.-P. 28−32.
- Ludwig D.S., Peterson K.E., Gortmaker S.L. Relation between consumption of sugar-sweetened drinks and childhood obesity: a prospective, observational analysis // Lancet. 2001. — Vol. 357. — P. 505−508.
- Lutz R.A., Cruciani R.A., Munson P.J. et al. Mui: very high affinity subtype of enkephalin binding sites in rat brain // Life Sci. 1985. — Vol. 36. — N 23. -P. 2233−2238.
- Lyupina Y.V., Sudakov S.K., Yarygin V.N. Inhibitors of Ca (2+)-dependent endopeptidases modulate morphine-induced effects in rats // Eur. J. Pharmacol. 1996. — Vol. 304. — N 1−3. — P. 23−27.
- Maher C.E., Selley D.E., Childers S.R. Relationship of |i opioid receptor binding to activation of G-proteins in specific rat brain regions // Biochem Pharmacol. 2000. — Vol. 59. — P. 1395−1401.
- Mains R.E., Eipper B.A., Ling N. Common precursor to corticotropins and endorphins //Proc.Natl.Acad.Sci. U.S.A. — 1977. — Vol. 74. — P. 3014−3018.
- Mansour A., Lewis M.W., Khachaturian H. et al. Pharmacological and anatomical evidence of selective mu, delta and kappa opioid receptor binding in rat brain // Brain Res. 1986. — Vol. 399. — N 1. — P. 69−79.
- Marks-Kaufman R., Kanarek R.B. Morphine selectively influences macronutrient intake in the rat // Pharmacol Biochem Behav. 1980. — Vol. 12.-P. 42730.
- Martin W.R. Opioid antagonist // Pharmacol. Rev. 1967. — Vol. 19. — N 4. -P. 464−521.
- Martin W.R., Eades C.G., Thompson J.A., Huppler R.E., Gilbert P.E. The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog // J. Pharmacol. Exp. Ther. 1976. -Vol. 197.-P. 517−532.
- Martin W.R., Wikler A., Eades C.G., and Pescor F.T. Tolerance to and physical dependence on morphine in rats // Psychopharmacologia. 1963. -Vol. 4. — P. 247−260.
- Matsumura M., Fukushima T., Saito H. et al. In vivo and in vitro effects of beta-endorphin on glucose metabolism in the rat // Horm. Metab. Res. -1984.-Vol. 16. N 1. — P. 27−31.
- McFarland K., Kalivas P.W. The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior // J. Neurosci. 2001. — Vol. 21. — P. 8655−8663.
- Mcintosh C.H., Kwok Y.N., Mordhost T. et al. Enkephalinergic control of somatostatin secretion from the perfused rat stomach // Can. J. Physiol. Pharmacol. 1983. — Vol. 61. — N 7. — P. 657−663.
- McLean S., Rothman R.B., Herkenham M. Autoradiographic localization of mu- and delta-opioid receptors in the forebrain of the rat // Brain Res. -1986. Vol. 378. — N 1. — P. 49−60.
- Mehrishi J.N., Mills I.N. Opiate receptors on lymphocytes and platelets in man // Clin. Immunol. Immmunopathol. 1983. — Vol. 27. — N 2. — P. 240 249.
- Menendez L., Lastra A., Meana A., Hidalgo A., Baamonde A. Analgesic effects of loperamide in bone cancer pain in mice // Pharmacol Biochem Behav. 2005. — Vol. 81. — P. 114−121.
- Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., et al. Isolation and structure of the endogenous agonist of opioid receptorlike ORL1 receptor//Nature. 1995. — Vol. 377. — P. 532−535.
- Morley J.E., Levina A.S., Silves S.E. Central regulation of gastric acid secretion: the role of neuropeptides // Life Sci. 1982. — Vol. 31. — N 5. — P. 399−410.
- Morley J.E., Levine A.S., Yim G.K., Lowy M.T. Opioid modulation of appetite // Neurosci Biobehav Rev. 1983. — Vol. 7. — N 2. — P. 281−305.
- Nakanishi S., Inoue A., Kita T., Nukamura M., Chung A.C.Y., Cohen S.N., Numa S, Nucleotide Sequence of Cloned cDNA for Bovine Corticotropin-beta-lipotropin Precursor // Nature. 1979. — Vol. 278. — P. 423−427.
- Nakaya Y., Kaneko T., Shigemoto R., Nakanishi S., Mizuno N. Immunohistochemical localization of substance P receptor in the central nervous system of the adult rat // J. Comp. Neurol. 1994. — Vol. 347. — P. 249−274.
- Nathan P.J., Bullmore E.T. From taste hedonics to motivational drive: central mu-opioid receptors and binge-eating behavior // Int. J. Neuropsychopharmacol. 2009. — Vol. 12 — P. 1−14.
- Negus S.S., Mello N.K. Opioid antinociception in ovariectomized monkeys: comparison with antinociception in males and effects of estradiol replacement. J Pharmacol Exp Ther. 1999. — Vol. 290. — P. 1132−1140.
- Neil A., Lahti R.A., Lindeberg G., Terenius L. Des-tyrosinel-y-endorphin increases the antinociceptive efficacy of morphine in the rat // Eur. J. Pharmacol. 1981. — Vol. 76. — N 1. — P. 93−95.
- Neves S.R., Ram P.T., Iyengar R. G protein pathways // Science. 2002. -Vol. 296.-P. 1636−1639.
- Nishimura E., Buchan A.M.J., Mcintosh C.H.S. Autoradiographic localization of mu- and delta-type opioid receptors in the gastrointertinal tract of the rat and guinea pig // Gastroenterology. 1986. — Vol. 91. — N 5. -P. 1084−1094.
- Nozaki-Taguchi N., Yaksh T.L. Characterization of the antihyperalgesic action of a novel peripheral mu-opioid receptor agonist—loperamide // Anesthesiology. 1999. — Vol. 90. — P. 225−234.
- Nutt D.J. Addiction: brain mechanisms and their treatment implications // Lancet. 1996. — Vol. 347. — N 8993. — P. 31.obesity. Obes Res. 1999. — Vol. 7. — N 5. P. 498−505.
- Olszewski P.K., Grace M.K., Sanders J.B., et al. Effect of nociceptin/orphanin FQ on food intake in rats that differ in diet preference // Pharmacology Biochemistry and Behavior. 2002. — Vol. 73. — N 3. — P. 529 535.
- Olszewski P.K., Levine A.S. Central opioids and consumption of sweet tastants: when reward outweighs homeostasis // Physiol Behav. 2007. -Vol. 91.-P. 506−512.
- Ossipov M.H., Lai J., King T. et al. Antinociceptive and nociceptive actions of opioids // J. Neurobiol. 2004. — Vol. 61. — N 1. — P. 126−148.
- Pan Y.X., Xu J., Bolan E., Moskowitz H.S., Xu M., Pasternak G.W. Identification of four novel exon 5 splice variants of the mouse mu-opioid receptor gene: functional consequences of C-terminal splicing // Mol Pharmacol. 2005. — Vol. 68. — P. 866−875.
- Pan Z. Z. mu-Opposing actions of the kappa- opioid receptor // Trends in Pharmacol. Sci. 1998. — Vol. 19. — P. 94−98.
- Panksepp J. Affective consciousness: Core emotional feelings in animals and humans // Consciousness and Cognition. 2005. — Vol. 14. — N 1. — P. 30−80.
- Pasternak D.A., Pan L., Xu J., et al. Identification of three new alternatively spliced variants of the rat mu opioid receptor gene: dissociation of affinity and efficacy // J Neurochem. 2004. — Vol. 91. — P. 881−890.
- Pasternak G.W., Gintzler A.R., Houghten R.A. et al. Biochemical and pharmacological evidence for opioid receptor multiplicity in the central nervous system // Life Sci. 1983. — Vol. 33. — N 1. — P. 167−173.
- Pasternak G.W., Snyder S.H. Identification of novel high affinity opiate receptor binding in rat brain // Nature. 1975. — Vol.253. — N 5492. — P. 563 565.
- Paterson S.J., Robson L.E., Kosterlitz H.W. Classification of opioid receptors // Brit. Med. Bull. 1983. — Vol. 39. — N 1. — P. 31−36.
- Paton W.D.M. The action of morphine and related substances on contraction and on acetycholine output of coalixially stimulated guinea pig ileum // Br. J. Pharmacol. 1957. -Vol. 12 -Nl.- P. 119−127.
- Paxinos G., Watson C. The rat brain in stereotaxic coordinates. N.Y., 1998.
- Pecina S., Berridge K.C. Hedonic hot spot in nucleus accumbens shell: Where do mu-opioids cause increased hedonic impact of sweetness? // J. Neurosci. 2005. — Vol. 25. — N 50. — P. 11 777−11 786.
- Persson L., Hillered L. Chemical monitoring of neurosurgical intensive care patients using intracerebral microdialysis // J. Neurosurg. 1992. — Vol. 76. -N 1. — P. 72−80.
- Pert C.B., Snyder S.H. Opiater receptors: demonstration in nervous tissue // Science. 1973.- Vol. 179. — N4077. — P. 1011−1014.
- Pfeiffer A., Pasi A., Mehraein P. et al. Opiate receptor binding sites in human brain // Brain Res. 1982. — Vol. 248. — N 1. — P. 87−96.
- Pickel V.M., Douglas J., Chan J., Gamp P.D., Bunnett N.W. Neurokinin 1 receptor distribution in cholinergic neurons and targets of substance P terminals in the rat nucleus accumbens // J. Comp. Neurol. 2000. — Vol. 423.-P. 500−511.
- Pieretti S., Di Giannuario A., Loizzo A. Des-tyrosine-gamma-endorphin effects on morphine analgesia in mice. // Gen. Pharmacol. 1993. — Vol. 24. -Nl.-P. 83−88.
- Poulin J.F., Chevalier B., Laforest S., Drolet G. Enkephalinergic afferents of the centromedial amygdala in the rat // J. Comp. Neurol. 2006. — Vol. 496. -P. 859−876.
- Piihler W., Rittner H.L., Mousa S.A. et al. Interleukin-1 beta contributes to the upregulation of kappa opioid receptor mRNA in dorsal root ganglia in response to peripheral inflammation // Neuroscience. 2006. — Vol. 141. — N 2. — P. 989−998.
- Rada P., Avena N.M., Hoebel B.G. Daily bingeing on sugar repeatedly releases dopamine in the accumbens shell // Neuroscience. 2005. — Vol. 134. — P. 737−744.
- Raynor K., Kong H., Chen Y., Yasuda K., Yu L., Bell G.I., et al. Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors // Mol. Pharmacol. 1994. — Vol. 45. — P. 330−334.
- Reisine T., Pasternak G. // In: Pharmacological basis of therapies // Goodam Gilman. 1995. — Vol. 9. — P. 521−564.
- Richard J. Bodnar Endogenous Opiates and Behavior: 2006 // Peptides. -2007. Vol. 28. — N 12. — P. 2435−2513.
- Richards M.L., Sadee W. In vivo binding of the benzomorphans to mu, delta and kappa opioid receptors: comparison with urine output in the rat // J. Pharmacol. Exp. Ther. 1985. — Vol. 233. — N 2. — P. 425−440.
- Riepl R.L., Reichardt B., Auernhammer C.J., Beier G., Schopohl J., Stalla G.K., Lehnert P. Suppression of vagus-mediated pancreatic polypeptide release by the ji-opiate receptor agonist loperamide // Br. J. Clin. Pharmacol. 1996.-Vol. 46.-P. 371−377.
- Rios C.D., Jordan B.A., Gomes I., Devi L.A. G-protein-coupled receptor dimerization: modulation of receptor function // Pharmacol. Ther. 2001. -Vol. 92.-P. 71−87.
- Rotman R.B., Westfall T.C. Morphine allosterically modulates the binding of H-leucine-enkephalin to a particulate fraction of rat brain // Molec. Pharmacol. 1982. — Vol. 21. — N 3. — P. 338−547.
- Satoh M., Minami M. Molecular pharmacology of the opioid receptors // Pharmacol. Ther. 1995. — Vol. 68. — N 3. — P. 343−364.
- Schafer M.K., Day R., Ortega M.R., Akil H., Watson S.J. Proenkephalin messenger RNA is expressed both in the rat anterior and posterior pituitary // Neuroendocrinology. 1990. Vol. 51. — N 4. — P. 444−448.
- Schaumann W. The paralysing action of morphine on the guinea pig ileum. // Br. J. Pharmacol. 1955. — Vol. 10. — N 4. — P. 456−461.
- Schwartzberg D.G., Nakane P.K. ACTH-related peptide containing neurons within the medulla oblongata of the rat // Brain Res. 1983. — Vol. 276. — P. 351−356.
- Scott D.J., Stohler C.S., Koeppe R.A., Zubieta J.K. Time-course of change in llC. carfentanil and [llC]raclopride binding potential after a nonpharmacological challenge // Synapse. 2007. — Vol. 61. — P. 707−714.
- Selley D.E., Liu Q., Childers S.R. Signal transduction correlates of |x opioid agonist intrinsic efficacy: receptor-stimulated 35S. GTPyS binding in mMOR-CHO cells and rat thalamus // J. Pharmacol. Exp. Ther. 1998. -Vol. 285. — P. 496−505.
- Sevostianova N., Danysz W., Bespalov A.Y. Analgesic effects of morphine and loperamide in the rat formalin test: Interactions with NMDA receptor antagonists // Eur. J. Pharmacol. 2005. — Vol. 525. — P. 83−90.
- Shimomura Y., Oku J., Glick Z., Bray G.A. Opiate receptors, food intake and obesity // Physiol Behav. 1982. — Vol. 28. — N 3. — P. 441−445.
- Shook J.E., Pelton J.T., Hruby V.J., Burks T.F. Peptide opioid antagonist separates peripheral and central opioid antitransit effects // J. Pharmacol. Exp. Ther. 1987. — Vol. 243. — P. 492−500.
- Simantov R., Childers S.R., Snyder S.H. 3H.Opiate binding: Anomalous properties in kidney and liver membranes // Mol. Pharmacol. 1978. — Vol. 14.-N l.-P. 69−76.
- Simon E.J., Hiller J.M., Edelman I. Stereoshecific binding of the potent narcotic analgesic H-etorrphine to rat brain homogenate // Proc. Natl. Acad. Sci. USA. — 1973. — Vol. 70. — N 7. — P. 1947−1949
- Simon M.I., Strathmann M.P., Gautam N. Diversity of G proteins in signal transduction // Science. 1991. — Vol. 252. — P. 802−808.
- Sim-Selley L.J., Daunais J.B., Porrino L.J., Childers S.R. jj, and k1 opioid-stimulated 35S. guanylyl-5'-0-(y-thio)-triphosphate binding in cynomolgus monkey brain // Neuroscience. 1999. — Vol. 94. — P. 651−662.
- Smith K.S., Berridge K.C. Opioid limbic circuit for reward: Interaction between hedonic hotspots of nucleus accumbens and ventral pallidum // J. Neurosci. 2007. — Vol. 27. — N 7. — P. 1594−1605.
- Snook L.A., Milligan G., Kieffer B.L., Massotte D. Mu-delta opioid receptor functional interaction: insight using receptor-G protein fusions // J. Pharmacol. Exp. Ther. 2006. — Vol. 318. — P. 683−690.
- Spangler R., Wittkowski K.M., Goddard N.L., Avena N.M., Hoebel B.G., et al. Opiate-like effects of sugar on gene expression in reward areas of the rat brain // Brain Res Mol Brain Res. 2004. — Vol. 124. — P. 134−142.
- Stein C. Opioid receptors on peripheral sensory neurons / C. Stein // Adv. Exp. Med. Biol. 2003. Vol. 521. P. 69−76.
- Suzuki T., Misawa W. Opioid receptor types and dependence // Nippon Yakurigaku Zasshi. 1997. — Vol. 109. — N 4. — P. 165.
- Tan-No K., Niijima F., Nakagawasai O., Sato T., Satoh S., Tadano T: Development of tolerance to the inhibitory effect of loperamide on gastrointestinal transit in mice. Eur J Pharm Sci. 2003. — Vol. 20. — N 3. -P. 357−363.
- Taylor J.W., Kaiser E.T. The structural characterization of beta-endorphin and related peptide hormones and neurotransmitters // Pharm. Rev. 1986. -Vol. 38.-N 4. — P. 291−312.
- Terenius L. Stereospecific interaction between narcotic analgesic and a synaptic plasma membrane fraction of the rat cerebral cortex // Acta Pharmacol., Toxicol. 1973. — Vol. 32. — N 3−4. — P. 317−320.
- Teschemacher H., Koch G., Brantl V. Milk protein-derived opioid receptor ligands // Biopolymers. 1997 — Vol. 43 — N 2 — P. 99−117.
- Traynor J.R. Opioid binding sites in the spinal cord // Trends Pharmacol. Sci. 1984. — Vol. 7. — N 8. — P. 495−496.
- Tsao P., Von Zastrow M. Diversity and specificity in the regulated endocytic membrane trafficking of G-protein-coupled receptors // Pharmacol Ther. 2001. — Vol. 89. — P. 139−47.
- Vander Tuig J.G., Beneke W.M. Low-protein diet blocks development of
- Von Zastrow M. Opioid receptor regulation / von M. Zastrow // Neuromolecular Med. 2004. — Vol. 5. — N 1. — P. 51−58.
- Welch C.C., Kim E.M., Grace M.K., Billington C.J., and Levine A.S. Palatability-induced hyperphagia increases hypothalamic Dynorphin peptide and mRNA levels // Brain Res. 1996. — Vol. 721. — P. 126−131.
- White F.J. A behavioral/systems approach to the neuroscience of drug addiction // J. Neurosci. 2002. — Vol. 22. — N 9. — P. 3303.
- Will M.J., Franzblau E.B., Kelley A.E. Nucleus accumbens mu-opioids regulate intake of a high-fat diet via activation of a distributed brain network // J. Neurosci. 2003. — Vol. 23. — P. 2882−2888.
- Will M.J., Franzblau E.B., Kelley A.E. The amygdala is critical for opioid-mediated binge eating of fat // Neuroreport. 2004. — Vol. 15. — P. 18 571 860.
- Williams J.T., Christie M.J., Manzoni O. Cellular and synaptic adaptations mediating opioid dependence // Physiol Rev. 2001. — Vol. 81. — P. 299−343.
- Wise R.A. Forebrain substrates of reward and motivation // J. Comp. Neurol. 2005. — Vol. 493. — P. 115−121.
- Wise R.A., Bozarth M.A. Brain mechanisms of drug reward and euphoria // Psychiatr. Med. 1985. — Vol. 3. — P. 44560.
- Wong C.L. The involvement of 13-endorphin in swin-induced antinociception in female mice // Arch. Int. Pharmacodyn. Ther. 1989. -Vol. 300. — P. 22−28.
- Wood J.D., Galligan J.J. Function of opioids in the enteric nervous system // Neurogastroenterol. Motil. 2004. — Vol. 16. — N 2. — P. 17−28.
- Wybran J. Enkephalins and endorphins as modifiers of immune systemA present and future // Fed. Proc. 1985. — Vol. 44. — N 2. — P. 92−94.
- Wybran J., Appelboom T., Famaey J.P. et al. Receptors for morphine and methinine-enkephalin on human T-lymphocytes: the two hits opioid lymphocyte receptor hypothesis // New Trands Human Immunol. Cancer Immunother. (Proc.) Paris. — 1980.
- Wybran J., Appelboom T., Famaey J.P. et al. Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T- lymphocytes // J. Immunol. 1979. — Vol. 123. — N 3. — P. 1068−1070.
- Xiao R.P., Pepe S., Spurgeon H.A. et al. Opioid peptide receptor stimulation reverses (i-adrenergic effects in rat heart cells // Am. J. Physiol. 1997. -Vol. 272. — P. 797−805.
- Xu J., Xu M., Pan Y.X. Chracterizing exons 11 and 1 promoters of the mu opioid receptor (Oprm) gene in transgenic mice // BMC Mol Biol. 2006. -Vol. 7.-P. 41.
- Yamanouchi K., Yanaga K., Okudaira S. et al. D-Ala2, D-Leu5. enkephalin (DADLE) protects liver against ischemia-reperfusion injury in the rat // J. Surg. Res. 2003. — Vol. 114. — N 1. — P. 72−77.
- Yuan C.S., Wang C.Z., Attele A., Zhang L. Methylnaltrexone reduced body weight gain in ob/ob mice // J. Opioid. Manag. 2009. — Vol. 4. — P. 213−218.
- Zadina J.E., Hackler L., Ge L.J., Kastin A.J. A potent and selective endogenous agonist for the |j,-opiate receptor // Nature. 1997. — Vol. 386. -P. 499−502.
- Zajac J.M., Gacel G. Petit F. et al. Deltakephalin, Tyr-D-Thr-Gly-Phe-Leu-Thr: a new highly potent and fully specific agonist for opiate delta-receptors // Biochem. Biophys. Res. Communs. 1983. — Vol. 3. — N 2. — P. 390−397.
- Zaki P.A., Bilsky E.J., Vanderah T.W., Lai J., Evans C.J., Porreca F. Opioid receptor types and subtypes: the delta receptor as a model // Annu Rev Pharmacol Toxicol. 1996. — Vol. 36. — P. 379−401.
- Zhang M., Kelley A.E. Opiate agonists microinjected into the nucleus accumbens enhance sucrose drinking in rats // Psychopharmacology (Berl). -1997.-Vol. 132.-P. 350−360.
- Zollner C., Shaqura M.A., Bopaiah C.P. et al. Painful Inflammation-Induced Increase in mu-Opioid Receptor Binding and G-Protein Coupling in Primary Afferent Neurons // Mol. Pharmacol. 2003. — Vol. 64. — P. 202−210.
- Zubieta J. K, Smith Y. R, Bueller J. A, Xu Y., Kilbourn M.R., Jewett D.M., Meyer C.R., Koeppe R.A., Stohler C.S. |i-Opioid receptor-mediatedantinociceptive responses differ in men and women // J Neurosci. 2002. -Vol. 22.-P. 51 200−55 107.